{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,2]],"date-time":"2025-03-02T05:16:41Z","timestamp":1740892601394,"version":"3.38.0"},"reference-count":22,"publisher":"Japanese Society of Toxicology","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Toxicol. Sci."],"published-print":{"date-parts":[[2025]]},"DOI":"10.2131\/jts.50.125","type":"journal-article","created":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T22:20:43Z","timestamp":1740781243000},"page":"125-134","source":"Crossref","is-referenced-by-count":0,"title":["Male rat-specific fatty change in liver by DS-1971a: Elevation in phospholipids and adenosine as early responses to the fatty change in male rat-derived primary hepatocytes"],"prefix":"10.2131","volume":"50","author":[{"given":"Kazunori","family":"Fujimoto","sequence":"first","affiliation":[{"name":"Medicinal Safety Research Laboratories, Daiichi Sankyo Co., Ltd."},{"name":"Tissue and Cell Research Center Munich, Daiichi Sankyo Europe GmbH, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Kishino","sequence":"additional","affiliation":[{"name":"Medicinal Safety Research Laboratories, Daiichi Sankyo Co., Ltd."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Hirao","sequence":"additional","affiliation":[{"name":"Regulatory Affairs Strategy Department, Daiichi Sankyo Co., Ltd."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takanori","family":"Maejima","sequence":"additional","affiliation":[{"name":"Translational Science, Daiichi Sankyo, Inc., USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiko","family":"Mori","sequence":"additional","affiliation":[{"name":"Medicinal Safety Research Laboratories, Daiichi Sankyo Co., Ltd."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshimi","family":"Tsuchiya","sequence":"additional","affiliation":[{"name":"Medicinal Safety Research Laboratories, Daiichi Sankyo Co., Ltd."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"898","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"Arendt, B.M., Ma, D.W., Simons, B., Noureldin, S.A., Therapondos, G., Guindi, M., Sherman, M. and Allard, J.P. (2013): Nonalcoholic fatty liver disease is associated with lower hepatic and erythrocyte ratios of phosphatidylcholine to phosphatidylethanolamine. Appl. Physiol. Nutr. Metab., <b>38<\/b>, 334-340.","DOI":"10.1139\/apnm-2012-0261"},{"key":"2","doi-asserted-by":"crossref","unstructured":"Ben M\u2019barek, K., Ajjaji, D., Chorlay, A., Vanni, S., For\u00eat, L. and Thiam, A.R. (2017): ER membrane phospholipids and surface tension control cellular lipid droplet formation. Dev. Cell, <b>41<\/b>, 591-604.e7.","DOI":"10.1016\/j.devcel.2017.05.012"},{"key":"3","doi-asserted-by":"crossref","unstructured":"Boison, D., Scheurer, L., Zumsteg, V., R\u00fclicke, T., Litynski, P., Fowler, B., Brandner, S. and Mohler, H. (2002): Neonatal hepatic steatosis by disruption of the adenosine kinase gene. Proc. Natl. Acad. Sci. USA, <b>99<\/b>, 6985-6990.","DOI":"10.1073\/pnas.092642899"},{"key":"4","doi-asserted-by":"crossref","unstructured":"Donato, M.T. and G\u00f3mez-Lech\u00f3n, M.J. (2012): Drug-induced liver steatosis and phospholipidosis: cell-based assays for early screening of drug candidates. Curr. Drug Metab., <b>13<\/b>, 1160-1173.","DOI":"10.2174\/138920012802850001"},{"key":"5","doi-asserted-by":"crossref","unstructured":"Evans, A.M., DeHaven, C.D., Barrett, T., Mitchell, M. and Milgram, E. (2009): Integrated, nontargeted ultrahigh performance liquid chromatography\/electrospray ionization tandem mass spectrometry platform for the identification and relative quantification of the small-molecule complement of biological systems. Anal. Chem., <b>81<\/b>, 6656-6667.","DOI":"10.1021\/ac901536h"},{"key":"6","doi-asserted-by":"crossref","unstructured":"Fagone, P. and Jackowski, S. (2013): Phosphatidylcholine and the CDP-choline cycle. Biochim. Biophys. Acta, <b>1831<\/b>, 523-532.","DOI":"10.1016\/j.bbalip.2012.09.009"},{"key":"7","doi-asserted-by":"crossref","unstructured":"Fujimoto, K., Kishino, H., Yamoto, T., Manabe, S. and Sanbuissho, A. (2010): In vitro cytotoxicity assay to evaluate the toxicity of an electrophilic reactive metabolite using glutathione-depleted rat primary cultured hepatocytes. Chem. Biol. Interact., <b>188<\/b>, 404-411.","DOI":"10.1016\/j.cbi.2010.09.012"},{"key":"8","doi-asserted-by":"crossref","unstructured":"Fujimoto, K., Kishino, H., Hashimoto, K., Watanabe, K., Yamoto, T. and Mori, K. (2020): Biochemical profiles of rat primary cultured hepatocytes following treatment with rotenone, FCCP, or (+)-usnic acid. J. Toxicol. Sci., <b>45<\/b>, 339-347.","DOI":"10.2131\/jts.45.339"},{"key":"9","doi-asserted-by":"crossref","unstructured":"Ganti, S., Taylor, S.L., Kim, K., Hoppel, C.L., Guo, L., Yang, J., Evans, C. and Weiss, R.H. (2012): Urinary acylcarnitines are altered in human kidney cancer. Int. J. Cancer, <b>130<\/b>, 2791-2800.","DOI":"10.1002\/ijc.26274"},{"key":"10","doi-asserted-by":"crossref","unstructured":"Gluchowski, N.L., Becuwe, M., Walther, T.C. and Farese, R.V. Jr. (2017): Lipid droplets and liver disease: from basic biology to clinical implications. Nat. Rev. Gastroenterol. Hepatol., <b>14<\/b>, 343-355.","DOI":"10.1038\/nrgastro.2017.32"},{"key":"11","doi-asserted-by":"crossref","unstructured":"Ipsen, D.H., Lykkesfeldt, J. and Tveden-Nyborg, P. (2018): Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver disease. Cell. Mol. Life Sci., <b>75<\/b>, 3313-3327.","DOI":"10.1007\/s00018-018-2860-6"},{"key":"12","doi-asserted-by":"crossref","unstructured":"Li, Z., Agellon, L.B., Allen, T.M., Umeda, M., Jewell, L., Mason, A. and Vance, D.E. (2006): The ratio of phosphatidylcholine to phosphatidylethanolamine influences membrane integrity and steatohepatitis. Cell Metab., <b>3<\/b>, 321-331.","DOI":"10.1016\/j.cmet.2006.03.007"},{"key":"13","doi-asserted-by":"crossref","unstructured":"Li, H., Zheng, J., Xu, Q., Yang, Y., Zhou, J., Guo, X., Cai, Y., Cai, J.J., Xie, L., Awika, J., Han, X., Li, Q., Kennedy, L., Francis, H., Glaser, S., Huo, Y., Alpini, G. and Wu, C. (2023): Hepatocyte adenosine kinase promotes excessive fat deposition and liver inflammation. Gastroenterology, <b>164<\/b>, 134-146.","DOI":"10.1053\/j.gastro.2022.09.027"},{"key":"14","doi-asserted-by":"publisher","unstructured":"Mart\u00ednez-U\u00f1a, M., Varela-Rey, M., Cano, A., Fern\u00e1ndez-Ares, L., Beraza, N., Aurrekoetxea, I., Mart\u00ednez-Arranz, I., Garc\u00eda-Rodr\u00edguez, J.L., Buqu\u00e9, X., Mestre, D., Luka, Z., Wagner, C., Alonso, C., Finnell, R.H., Lu, S.C., Mart\u00ednez-Chantar, M.L., Aspichueta, P. and Mato, J.M. (2013): Excess S-adenosylmethionine reroutes phosphatidylethanolamine towards phosphatidylcholine and triglyceride synthesis. Hepatology, <b>58<\/b>, 1296-1305.","DOI":"10.1002\/hep.26399"},{"key":"15","doi-asserted-by":"crossref","unstructured":"Mattes, W.B. (2020): In vitro to <i>in vivo<\/i> translation. Curr. Opin. Toxicol., <b>23-4<\/b>, 114-118.","DOI":"10.1016\/j.cotox.2020.09.001"},{"key":"16","doi-asserted-by":"crossref","unstructured":"Peng, Z., Borea, P.A., Varani, K., Wilder, T., Yee, H., Chiriboga, L., Blackburn, M.R., Azzena, G., Resta, G. and Cronstein, B.N. (2009): Adenosine signaling contributes to ethanol-induced fatty liver in mice. J. Clin. Invest., <b>119<\/b>, 582-594.","DOI":"10.1172\/JCI37409"},{"key":"17","doi-asserted-by":"crossref","unstructured":"Schumacher, J.D. and Guo, G.L. (2015): Mechanistic review of drug-induced steatohepatitis. Toxicol. Appl. Pharmacol., <b>289<\/b>, 40-47.","DOI":"10.1016\/j.taap.2015.08.022"},{"key":"18","doi-asserted-by":"crossref","unstructured":"Shields, D.J., Agellon, L.B. and Vance, D.E. (2001): Structure, expression profile and alternative processing of the human phosphatidylethanolamine N-methyltransferase (PEMT) gene. Biochim. Biophys. Acta, <b>1532<\/b>, 105-114.","DOI":"10.1016\/S1388-1981(01)00122-6"},{"key":"19","doi-asserted-by":"crossref","unstructured":"Shinozuka, T., Kobayashi, H., Suzuki, S., Tanaka, K., Karanjule, N., Hayashi, N., Tsuda, T., Tokumaru, E., Inoue, M., Ueda, K., Kimoto, H., Domon, Y., Takahashi, S., Kubota, K., Yokoyama, T., Shimizugawa, A., Koishi, R., Fujiwara, C., Asano, D., Sakakura, T., Takasuna, K., Abe, Y., Watanabe, T. and Kitano, Y. (2020): Discovery of DS-1971a, a potent, selective NaV1.7 inhibitor. J. Med. Chem., <b>63<\/b>, 10204-10220.","DOI":"10.1021\/acs.jmedchem.0c00259"},{"key":"20","doi-asserted-by":"crossref","unstructured":"Wan, S., Kuipers, F., Havinga, R., Ando, H., Vance, D.E., Jacobs, R.L. and van der Veen, J.N. (2019): Impaired hepatic phosphatidylcholine synthesis leads to cholestasis in mice challenged with a high-fat diet. Hepatol. Commun., <b>3<\/b>, 262-276.","DOI":"10.1002\/hep4.1302"},{"key":"21","doi-asserted-by":"crossref","unstructured":"Yao, Z.M. and Vance, D.E. (1988): The active synthesis of phosphatidylcholine is required for very low density lipoprotein secretion from rat hepatocytes. J. Biol. Chem., <b>263<\/b>, 2998-3004.","DOI":"10.1016\/S0021-9258(18)69166-5"},{"key":"22","doi-asserted-by":"crossref","unstructured":"Yao, Z.M. and Vance, D.E. (1990): Reduction in VLDL, but not HDL, in plasma of rats deficient in choline. Biochem. Cell Biol., <b>68<\/b>, 552-558.","DOI":"10.1139\/o90-079"}],"container-title":["The Journal of Toxicological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jts\/50\/3\/50_125\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T04:25:49Z","timestamp":1740803149000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jts\/50\/3\/50_125\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":22,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.2131\/jts.50.125","relation":{},"ISSN":["0388-1350","1880-3989"],"issn-type":[{"value":"0388-1350","type":"print"},{"value":"1880-3989","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]}}}